SG11201804540WA - Resorbable crosslinked form stable membrane - Google Patents
Resorbable crosslinked form stable membraneInfo
- Publication number
- SG11201804540WA SG11201804540WA SG11201804540WA SG11201804540WA SG11201804540WA SG 11201804540W A SG11201804540W A SG 11201804540WA SG 11201804540W A SG11201804540W A SG 11201804540WA SG 11201804540W A SG11201804540W A SG 11201804540WA SG 11201804540W A SG11201804540W A SG 11201804540WA
- Authority
- SG
- Singapore
- Prior art keywords
- collagen
- international
- collagen material
- composite layer
- inorganic ceramic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0003—Not used, see subgroups
- A61C8/0004—Consolidating natural teeth
- A61C8/0006—Periodontal tissue or bone regeneration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2/2846—Support means for bone substitute or for bone graft implants, e.g. membranes or plates for covering bone defects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/46—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/12—Materials or treatment for tissue regeneration for dental implants or prostheses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Botany (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Developmental Biology & Embryology (AREA)
- Dentistry (AREA)
- Rheumatology (AREA)
- Cell Biology (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Polymers & Plastics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15198070.3A EP3175869A1 (en) | 2015-12-04 | 2015-12-04 | Resorbable crosslinked formstable membrane |
PCT/EP2016/079622 WO2017093502A1 (en) | 2015-12-04 | 2016-12-02 | Resorbable crosslinked form stable membrane |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201804540WA true SG11201804540WA (en) | 2018-06-28 |
Family
ID=54782622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201804540WA SG11201804540WA (en) | 2015-12-04 | 2016-12-02 | Resorbable crosslinked form stable membrane |
Country Status (20)
Country | Link |
---|---|
US (1) | US10300171B2 (zh) |
EP (2) | EP3175869A1 (zh) |
JP (2) | JP6571872B2 (zh) |
KR (1) | KR101918908B1 (zh) |
CN (2) | CN108289976B (zh) |
AU (1) | AU2016361929B2 (zh) |
BR (1) | BR112018009975B1 (zh) |
CA (1) | CA3006693C (zh) |
DK (1) | DK3233146T3 (zh) |
ES (1) | ES2675230T3 (zh) |
HK (1) | HK1245681B (zh) |
HU (1) | HUE037840T2 (zh) |
IL (1) | IL259776B (zh) |
MX (1) | MX2018006786A (zh) |
PL (1) | PL3233146T3 (zh) |
PT (1) | PT3233146T (zh) |
RU (1) | RU2733387C9 (zh) |
SG (1) | SG11201804540WA (zh) |
TR (1) | TR201809139T4 (zh) |
WO (1) | WO2017093502A1 (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3175869A1 (en) * | 2015-12-04 | 2017-06-07 | Geistlich Pharma AG | Resorbable crosslinked formstable membrane |
EP3409303A1 (en) | 2017-06-02 | 2018-12-05 | Geistlich Pharma AG | Use of a resorbable crosslinked form stable composition for preparing a membrane |
ES2897211T3 (es) * | 2017-12-14 | 2022-02-28 | Geistlich Pharma Ag | Uso de una composición de implante seco para la preparación de una formulación de implante acuoso inyectable |
KR101938263B1 (ko) * | 2018-07-31 | 2019-01-14 | 강호창 | 치과용 이중구조 멤브레인의 제조방법 |
KR102618676B1 (ko) * | 2019-06-14 | 2023-12-27 | 가이스틀리히 파마 아게 | 아스코르브산을 함유하는 주사가능한 수성 임플란트 제형 |
CN111758763B (zh) * | 2020-07-07 | 2021-12-14 | 山东大树达孚特膳食品有限公司 | 一种肥肠去油脂设备 |
US12004914B2 (en) | 2021-09-09 | 2024-06-11 | Dip, Llc | Customized three-dimensional scaffold for oral and maxillofacial bone grafting |
CN114425104B (zh) * | 2021-12-21 | 2023-03-03 | 中国人民解放军空军军医大学 | 一种载药骨引导/诱导复合结构及其制备方法和应用 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8813033D0 (en) | 1988-06-02 | 1988-07-06 | Geistlich Soehne Ag | Chemical compound |
JPH0788174A (ja) * | 1993-09-28 | 1995-04-04 | Yamanouchi Pharmaceut Co Ltd | 骨形成用移植体 |
GB9400163D0 (en) | 1994-01-06 | 1994-03-02 | Geistlich Soehne Ag | Membrane |
JP3592920B2 (ja) * | 1998-01-19 | 2004-11-24 | 独立行政法人物質・材料研究機構 | 有機無機配向性複合材料の製造方法 |
JP4790917B2 (ja) * | 2001-02-23 | 2011-10-12 | 独立行政法人科学技術振興機構 | 人工椎体 |
US6713085B2 (en) * | 2001-04-27 | 2004-03-30 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Method and membrane for mucosa regeneration |
GB0121985D0 (en) * | 2001-09-11 | 2001-10-31 | Isis Innovation | Tissue engineering scaffolds |
RU2274461C2 (ru) * | 2004-02-26 | 2006-04-20 | Сергей Дмитриевич Литвинов | Материал для замещения дефектов костной ткани и способ его получения |
ITMI20050343A1 (it) * | 2005-03-04 | 2006-09-05 | Fin Ceramica Faenza S R L | Sostituto cartilagineo e osteocindrale comprendente una struttura multistrato e relativo impiego |
CA2749858C (en) * | 2009-01-16 | 2017-12-12 | Geistlich Pharma Ag | Method and membrane for skin regeneration |
EP2467172A1 (en) | 2009-08-10 | 2012-06-27 | Osseous Technologies Of America | Self-supporting collagen tunnel for guided tissue regeneration and method of using same |
DE102010001271B8 (de) * | 2010-01-27 | 2012-12-06 | Urotiss Gmbh | Vernähbares Gewebetransplantatkonstrukt zur Rekonstruktion eines menschlichen oder tierischen Organs |
GB201003656D0 (en) | 2010-03-05 | 2010-04-21 | Tigenix Ltd | Fabrication process |
EP2508212A1 (en) * | 2011-04-05 | 2012-10-10 | Universitätsklinikum Freiburg | Biocompatible and biodegradable gradient layer system for regenerative medicine and for tissue support |
RU2476236C1 (ru) * | 2012-02-16 | 2013-02-27 | Общество С Ограниченной Ответственностью "Ниармедик Плюс" | Композиционный материал для восстановления дефектов костной ткани, способ его получения и применение |
TWM435257U (en) * | 2012-04-27 | 2012-08-11 | Shih-Cheng Wen | Composite regeneration membrane |
CN102805881B (zh) * | 2012-06-18 | 2014-02-19 | 浙江星月生物科技股份有限公司 | 一种胶原基骨软骨三层复合物及其制备方法 |
US9943551B2 (en) * | 2012-08-15 | 2018-04-17 | Mimedx Group, Inc. | Tissue grafts composed of micronized placental tissue and methods of making and using the same |
US20140193477A1 (en) | 2012-10-11 | 2014-07-10 | Emory University | Collagen based materials and uses related thereto |
DE102012024206A1 (de) * | 2012-12-05 | 2014-06-18 | Celgen Ag | Mehrschichtige Membran für Knochendefekte |
CN104922732B (zh) * | 2014-03-19 | 2019-11-15 | 天新福(北京)医疗器材股份有限公司 | 一种口腔生物膜制备方法 |
EP3175869A1 (en) * | 2015-12-04 | 2017-06-07 | Geistlich Pharma AG | Resorbable crosslinked formstable membrane |
-
2015
- 2015-12-04 EP EP15198070.3A patent/EP3175869A1/en not_active Withdrawn
-
2016
- 2016-12-02 HU HUE16805151A patent/HUE037840T2/hu unknown
- 2016-12-02 PT PT168051514T patent/PT3233146T/pt unknown
- 2016-12-02 CN CN201680069895.1A patent/CN108289976B/zh not_active Expired - Fee Related
- 2016-12-02 TR TR2018/09139T patent/TR201809139T4/tr unknown
- 2016-12-02 RU RU2018119921A patent/RU2733387C9/ru active
- 2016-12-02 MX MX2018006786A patent/MX2018006786A/es active IP Right Grant
- 2016-12-02 WO PCT/EP2016/079622 patent/WO2017093502A1/en active Application Filing
- 2016-12-02 SG SG11201804540WA patent/SG11201804540WA/en unknown
- 2016-12-02 DK DK16805151.4T patent/DK3233146T3/en active
- 2016-12-02 KR KR1020187015487A patent/KR101918908B1/ko active IP Right Grant
- 2016-12-02 EP EP16805151.4A patent/EP3233146B1/en active Active
- 2016-12-02 CN CN201910799657.1A patent/CN110404116A/zh active Pending
- 2016-12-02 ES ES16805151.4T patent/ES2675230T3/es active Active
- 2016-12-02 PL PL16805151T patent/PL3233146T3/pl unknown
- 2016-12-02 BR BR112018009975-9A patent/BR112018009975B1/pt not_active IP Right Cessation
- 2016-12-02 CA CA3006693A patent/CA3006693C/en active Active
- 2016-12-02 JP JP2018528626A patent/JP6571872B2/ja not_active Expired - Fee Related
- 2016-12-02 AU AU2016361929A patent/AU2016361929B2/en not_active Ceased
-
2018
- 2018-04-19 HK HK18105106.0A patent/HK1245681B/zh not_active IP Right Cessation
- 2018-05-10 US US15/975,980 patent/US10300171B2/en active Active
- 2018-06-03 IL IL259776A patent/IL259776B/en active IP Right Grant
-
2019
- 2019-06-05 JP JP2019105189A patent/JP2019162503A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201804540WA (en) | Resorbable crosslinked form stable membrane | |
SG11201910191RA (en) | A peptide capable of forming a gel for use in tissue engineering and bioprinting | |
SG11201807965YA (en) | Combinations of lsd1 inhibitors for use in the treatment of solid tumors | |
SG11201808693WA (en) | Anti-il-33 antibodies, compositions, methods and uses thereof | |
SG11201906297QA (en) | Nucleic acids encoding crispr-associated proteins and uses thereof | |
SG11201804272RA (en) | Apparatus for controlled heart valve delivery | |
SG11201907804QA (en) | Pharmaceutical composition comprising selexipag | |
SG11201810628XA (en) | Nasal pharmaceutical compositions with a porous excipient | |
SG11201804152RA (en) | Heterocyclic compounds as immunomodulators | |
SG11201908971RA (en) | Erbb-2 and erbb3 binding bispecific antibodies for use in the treatment f cells that have an nrg1 fusion gene | |
SG11201807778YA (en) | Bicyclic compounds for diagnosis and therapy | |
SG11201900618WA (en) | Permanently polarized hydroxyapatite, a process for its manufacture and uses thereof | |
SG11201808566WA (en) | Polymorphic form of n-{6-(2-hydroxypropan-2-yl)-2-[2-(methylsulphonyl)ethyl]-2h-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide | |
SG11201907604UA (en) | Crystalline forms of the 4-pyrimidinesulfamide derivative aprocitentan | |
SG11201901534VA (en) | Combination therapy with controlled-release cnp agonists | |
SG11201807972YA (en) | Combinations of lsd1 inhibitors for the treatment of hematological malignancies | |
SG11201906959RA (en) | Aryl hydrocarbon receptor (ahr) modulator compounds | |
SG11201808222RA (en) | Methods of treatment of cholestatic diseases | |
SG11201807185UA (en) | Modified hyaluronic acid, method for making same and uses thereof | |
SG11201810352XA (en) | New antibacterial compounds | |
SG11201900546UA (en) | Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof | |
SG11201805195YA (en) | Composition comprising botulinum toxin | |
SG11201807963WA (en) | Compositions useful in the prevention and/or treatment of disorders of the oral cavity, upper airways and esophagus | |
SG11201900471VA (en) | Combination therapy for copd | |
SG11201809882XA (en) | Pharmaceutical combinations for treating cancer |